How Contessa’s Palliative Care Business Factored Into the Amedisys-Optum Transaction
Hospice News
SEPTEMBER 5, 2023
Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion.
Let's personalize your content